Skip to content

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03888482
Enrollment
154
Registered
2019-03-25
Start date
2019-04-26
Completion date
2019-06-28
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error, Myopia

Keywords

Visual acuity, VA, Daily disposable contact lenses

Brief summary

The purpose of this study was to evaluate visual acuity at distance when wearing DDT2 contact lenses compared to Clariti contact lenses.

Detailed description

Subjects were expected to attend 3 study visits and wear the DDT2 and Clariti study lenses in a crossover design for approximately 14 - 20 days (7 - 10 days for each product).

Interventions

Investigational daily disposable soft contact lenses

Commercially available daily disposable soft contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Able to understand and sign an Informed Consent Form that has been approved by an Institutional Review Board. * Willing and able to attend all scheduled study visits as required per protocol. * Current wearer of spherical soft contact lenses. Key

Exclusion criteria

* Any ocular condition that contraindicates contact lens wear. * Previous or current habitual wearer of clariti® or DAILIES TOTAL1® contact lenses.

Design outcomes

Primary

MeasureTime frameDescription
Least Squares Mean Distance Visual Acuity With Study LensesDay 8, each productVisual acuity was assessed and collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

Countries

United States

Participant flow

Recruitment details

This study was performed at 8 study centers in the United States (US).

Pre-assignment details

Of the 154 enrolled, 2 were exited from the study as screen failures and 1 subject was randomized but not exposed. This reporting group includes all exposed subjects (151).

Participants by arm

ArmCount
DDT2, Then Clariti
Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality. Verofilcon A contact lenses: Investigational daily disposable soft contact lenses Somofilcon A contact lenses: Commercially available daily disposable soft contact lenses
76
Clariti, Then DDT2
Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality. Verofilcon A contact lenses: Investigational daily disposable soft contact lenses Somofilcon A contact lenses: Commercially available daily disposable soft contact lenses
75
Total151

Withdrawals & dropouts

PeriodReasonFG000FG001
Second Wear (8 -1/+2 Days)Adverse Event01
Second Wear (8 -1/+2 Days)Other10

Baseline characteristics

CharacteristicClariti, Then DDT2TotalDDT2, Then Clariti
Age, Continuous31.8 years
STANDARD_DEVIATION 7.9
33.5 years
STANDARD_DEVIATION 8.1
35.1 years
STANDARD_DEVIATION 7.9
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants9 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
69 Participants142 Participants73 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Black or African American
1 Participants6 Participants5 Participants
Race/Ethnicity, Customized
Multi-racial
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
2 Participants3 Participants1 Participants
Race/Ethnicity, Customized
White
67 Participants132 Participants65 Participants
Region of Enrollment
United States
75 participants151 participants76 participants
Sex: Female, Male
Female
47 Participants103 Participants56 Participants
Sex: Female, Male
Male
28 Participants48 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 3020 / 1510 / 2980 / 149
other
Total, other adverse events
0 / 3020 / 1510 / 2980 / 149
serious
Total, serious adverse events
0 / 3020 / 1510 / 2980 / 149

Outcome results

Primary

Least Squares Mean Distance Visual Acuity With Study Lenses

Visual acuity was assessed and collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

Time frame: Day 8, each product

Population: Full analysis set (FAS): All randomized subjects/eyes with non-missing responses, who were exposed to any study lenses evaluated in this study, with the exception of the lenses used at Visit 1 for optimization and fitting.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
DDT2Least Squares Mean Distance Visual Acuity With Study Lenses-0.08 logMARStandard Error 0.006
ClaritiLeast Squares Mean Distance Visual Acuity With Study Lenses-0.08 logMARStandard Error 0.006
Mixed effects repeated measures model

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026